Precigen, Inc. (PGEN)
Company Info
Highlights
$410.30M
-$0.55
$4.20M
-$311.00K
-$120.48M
$0.65 - $2.17
$6.13
16.89%
19.76
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
Loading data...
Returns By Period
Precigen, Inc. (PGEN) returned 17.86% year-to-date (YTD) and -0.75% over the past 12 months. Over the past 10 years, PGEN returned -29.30% annually, underperforming the S&P 500 benchmark at 10.85%.
PGEN
17.86%
-15.38%
41.62%
-0.75%
-0.50%
-9.71%
-29.30%
^GSPC (Benchmark)
0.51%
6.15%
-2.00%
12.92%
12.68%
14.19%
10.85%
Monthly Returns
The table below presents the monthly returns of PGEN, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | 20.54% | 28.15% | -13.87% | 4.70% | -15.38% | 17.86% | |||||||
| 2024 | 2.99% | 11.59% | -5.84% | -8.97% | 6.06% | 12.86% | -3.80% | -27.63% | -13.90% | -16.78% | 18.26% | 20.16% | -16.42% |
| 2023 | 6.58% | -22.22% | -15.87% | 14.15% | -1.65% | -3.36% | 20.87% | 25.90% | -18.86% | -20.42% | -0.88% | 19.64% | -11.84% |
| 2022 | -30.46% | -12.79% | -6.22% | -36.97% | 0.75% | 0.00% | 17.16% | 40.76% | -4.07% | -23.58% | 12.35% | -16.48% | -59.03% |
| 2021 | -16.67% | -0.71% | -18.36% | 12.34% | -14.73% | -1.21% | -15.80% | 10.20% | -17.52% | -3.21% | -18.43% | -5.84% | -63.63% |
| 2020 | -15.15% | -18.49% | -10.29% | 5.88% | -38.89% | 126.82% | -15.63% | 43.71% | -42.15% | 22.57% | 84.62% | 28.79% | 86.13% |
| 2019 | 17.13% | 4.05% | -34.00% | -17.68% | 11.78% | 58.26% | 4.31% | -26.91% | -2.05% | -11.19% | 9.65% | -1.62% | -16.21% |
| 2018 | 12.85% | 0.15% | 17.74% | 18.59% | -8.80% | -15.92% | 5.16% | 4.91% | 11.96% | -32.87% | -15.22% | -33.27% | -43.23% |
| 2017 | -12.92% | 5.20% | -10.96% | 5.15% | 2.30% | 12.99% | -10.38% | -8.62% | -3.65% | -13.99% | -16.57% | -15.54% | -52.59% |
| 2016 | -3.35% | 6.21% | 9.50% | -21.13% | 15.00% | -19.94% | 2.93% | -0.36% | 11.01% | -6.85% | 11.80% | -16.72% | -19.40% |
| 2015 | 4.29% | 43.02% | 10.50% | -14.41% | 8.47% | 15.86% | 33.71% | -31.80% | -28.54% | 5.66% | 8.07% | -16.97% | 9.52% |
| 2014 | 41.05% | -22.61% | 1.19% | -28.19% | 11.71% | 19.16% | -12.10% | -8.19% | -8.38% | 20.13% | 18.86% | 3.77% | 15.67% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
The current rank of PGEN is 50, indicating average performance compared to other stocks on our website. Here’s a breakdown of how it compares using common performance measures.
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for Precigen, Inc. (PGEN) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Loading data...
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading data...
Worst Drawdowns
The table below displays the maximum drawdowns of the Precigen, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Precigen, Inc. was 99.02%, occurring on Dec 16, 2024. The portfolio has not yet recovered.
The current Precigen, Inc. drawdown is 98.08%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -99.02% | Aug 6, 2015 | 2357 | Dec 16, 2024 | — | — | — |
| -58.45% | Jan 21, 2014 | 76 | May 8, 2014 | 173 | Jan 14, 2015 | 249 |
| -40.57% | Aug 13, 2013 | 62 | Nov 7, 2013 | 43 | Jan 10, 2014 | 105 |
| -26.7% | Jan 15, 2015 | 6 | Jan 23, 2015 | 14 | Feb 12, 2015 | 20 |
| -22.81% | Mar 9, 2015 | 37 | Apr 29, 2015 | 36 | Jun 19, 2015 | 73 |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading data...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Precigen, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Earnings Per Share
The chart presents the Earnings Per Share (EPS) performance of Precigen, Inc., comparing actual results with analytics estimates. The company has exceeded analyst expectations for EPS in the past quarter, achieving a 37.0% positive surprise.
Valuation
The Valuation section provides an overview of how Precigen, Inc. is priced in the market compared to other companies in the Biotechnology industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for PGEN relative to other companies in the Biotechnology industry. Currently, PGEN has a P/S ratio of 97.7. This P/S ratio is high relative to other companies in the industry. It could mean the stock is overvalued, or that investors expect strong future growth and profitability.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for PGEN in comparison with other companies in the Biotechnology industry. Currently, PGEN has a P/B value of 7.3. This P/B ratio is higher than most companies in the industry. It may suggest the stock is overvalued or that investors expect the company to generate high returns on its assets.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |